FM
Fady Ibraham Malik (EVP Research & Development) filed 19 Form 4 reports in the trailing twelve months (0 purchases, 19 sales), most often in Cytokinetics, Incorporated (CYTK). The largest single filing was $748K of CYTK (12,033 sh across 2 lots, as filed), executed Mar 17. Data as of Nov 8 2026.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
19
0 buys · 19 sells
Median delay
–
measured on stock purchases
Volume, ttmiDollar value disclosed in the trailing twelve months
$4.7M
shares × price, as filed
Last traded
Nov 3
Filed Nov 3
Median ADV $207.8M across their filed names
Open performance→Volume by month
Buys $0
Sells $6.4M
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
19 filings
Sector per market data · by filing · past 12 months
Most traded names
CYTKRecent filings
CYTKSALE
Cytokinetics, Incorporated
View filing →
$135K2,200 sh × $61.24
Exec Dec 16 2025
Filed Dec 16 2025 · 5:30 PM ET CYTKSALE Cytokinetics, Incorporated View filing → $141K
2,200 sh × $63.89
Exec Dec 2 2025
Filed Dec 2 2025 · 5:30 PM ET CYTKSALE Cytokinetics, Incorporated View filing → $146K
2,200 sh × $66.45
Exec Nov 18 2025
Filed Nov 18 2025 · 5:30 PM ET CYTKSALE Cytokinetics, Incorporated View filing → $137K
2,295 sh × $59.55
Exec Nov 4 2025
Filed Nov 4 2025 · 5:30 PM ET CYTKSALE Cytokinetics, Incorporated View filing → $123K
2,105 sh × $58.22
Exec Oct 21 2025
Filed Oct 21 2025 · 5:30 PM ET CYTKSALE Cytokinetics, Incorporated View filing → $121K
2,000 sh × $60.56
Exec Oct 7 2025
Filed Oct 7 2025 · 5:30 PM ET CYTKSALE Cytokinetics, Incorporated View filing → $103K
2,000 sh × $51.29
Exec Sep 9 2025
Filed Sep 10 2025 · 5:30 PM ET CYTKSALE Cytokinetics, Incorporated View filing → $195K
4,389 sh × $44.38
Exec Mar 17 2025
Filed Mar 17 2025 · 5:30 PM ET More filings →